Viral-mediated gene delivery for cell-based assays in drug discovery

Expert Opinion on Drug Discovery

Volumn 4, Issue 3, 2009, Pages 243-256

  Ames, Robert S ^a   Lu, Quinn ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Adenovirus; Bacmam; Baculovirus; Cell based assays; Gene delivery; High throughput; Lentivirus; Retrovirus

Indexed keywords

ADENOVIRUS VECTOR; BACMAM VECTOR; BACULOVIRUS VECTOR; CELL ENZYME; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ION CHANNEL; LAMIN A; LAMIN C; LENTIVIRUS VECTOR; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; UROTENSIN II; VIRUS VECTOR; YELLOW FLUORESCENT PROTEIN;

ADENOVIRUS 2; ADENOVIRUS 5; BACMAM VIRUS; BACULOVIRUS; BIOCHEMICAL EQUIPMENT; BIOSAFETY; CELL BASED GENE THERAPY; CELL LINE; CELL TYPE; DNA VIRUS; DRUG TARGETING; FRIEND LEUKEMIA VIRUS; GENE EXPRESSION; GENE TARGETING; HEPATITIS C VIRUS; HIGH THROUGHPUT SCREENING; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS RECOMBINANT;

EID: 67649209037     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460440902751599     Document Type: Review

References (103)

1. Houston JG, Banks MN, Binnie A, et al. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006. Drug Discov Today 2008;13:44-51
2. Cawkill D, Eaglestone SS. Evolution of cell-based reagent provision. Drug Discov Today 2007;12:820-825 (Pubitemid 47539971)
3. Sewing A, Winchester T, Carnell P, et al. Helping science to succeed: improving processes in R&;D. Drug Discov Today 2008;13:227-233
4. Rees S, Wise A. The industrialisation of cellular screening. Expert Opin Drug Discov 2008;3:715-723
5. Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 1999;4:67-73 (Pubitemid 29278954)
6. Lotze MT, Kost TA. Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther 2002;9:692-699 (Pubitemid 34847578)
7. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001;7:33-40 (Pubitemid 32095639)
8. Bouard D, Azard-Dany N, Cosset FL. Viral vectors: from virology to transgene expression. Br J Pharmacol 2008 • A thorough review of the development and properties of viral vectors derived from retroviruses, adenoviruses, herpes simplex viruses and adeno-associated viruses.
9. Viral-mediated gene delivery poster. 2008. Available from: http://www.sciencemag.org/products/posters/GeneDeliveryPoster. PDF [Accessed 13 January 2009 ]
10. Boyce FM, Bucher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996;93:2348-2352 (Pubitemid 26104353)
11. Michiels F, van EH, van RL, et al. Arrayed adenoviral expression libraries for functional screening. Nat Biotechnol 2002;20:1154-1157 (Pubitemid 35285447)
12. Arts GJ, Langemeijer E, Tissingh R, et al. Adenoviral vectors expressing siRNAs for discovery and validation of gene function. Genome Res 2003;13:2325-2332 (Pubitemid 37265998)
13. Yauch RL, Kadel EE III, Nicholas C, et al. Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells. J Biomol Screen 2004;9:704-711 (Pubitemid 40491154)
14. Darrow AL, Conway KA, Vaidya AH, et al. Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screening. J Biomol Screen 2003;8:65-71 (Pubitemid 40503632)
15. Johns DG, Ao Z, Naselsky D, et al. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn Schmiedebergs Arch Pharmacol 2004;370:238-250 (Pubitemid 40063823)
16. Sorscher EJ, Harris J, Alexander M, et al. Activators of viral gene expression in polarized epithelial monolayers identified by rapid-throughput drug screening. Gene Ther 2006;13:781-788
17. Zhao L, Haslam DB. A quantitative and highly sensitive luciferase-based assay for bacterial toxins that inhibit protein synthesis. J Med Microbiol 2005;54:1023-1030 (Pubitemid 41566771)
18. Borkow G, Lara HH, yash-Rashkovsky M, et al. Adenovirus expressing a bioluminescence reporter gene and cMAGI cell assay for the detection of HIV-1. Virus Genes 2004;29:257-265
19. Hoyt J, King RW. Adenoviral expression of reporter proteins for high-throughput cell-based screening. Methods Mol Biol 2005;310:187-195
20. Kost TA, Condreay JP, Mickelson CA. Biosafety and viral gene transfer vectors. Fourth edition. In: Fleming DOHDL, editor, Biological Safety, Principles and Practices, American Society for Microbiology Press, 2006 . p. 509-530 • A recent review on the biosafety of viral vectors.
21. Paddison PJ, Silva JM, Conklin DS, et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 2004;428:427-431 (Pubitemid 38419688)
22. Berns K, Hijmans EM, Mullenders J, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004;428:431-437 (Pubitemid 38419689)
23. Razorenova OV, Ivanov AV, Budanov AV, et al. Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1. Gene 2005;350:89-98 (Pubitemid 40503148)
24. Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003;9:493-501 (Pubitemid 36356735)
25. Ngo VN, Davis RE, Lamy L, et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 2006;441:106-110 (Pubitemid 43827960)
26. Royer Y, Menu C, Liu X, et al. High-throughput gateway bicistronic retroviral vectors for stable expression in mammalian cells: exploring the biologic effects of STAT5 overexpression. DNA Cell Biol 2004;23:355-365 (Pubitemid 38850383)
27. Buchholz CJ, Duerner LJ, Funke S, et al. Retroviral display and high throughput screening. Comb Chem High Throughput Screen 2008;11:99-110 (Pubitemid 351347214)
28. Root DE, Hacohen N, Hahn WC, et al. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods 2006;3:715-719 (Pubitemid 44275739)
29. Sumimoto H, Kawakami Y. Lentiviral vector-mediated RNAi and its use for cancer research. Future Oncol 2007;3:655-664
30. Lesch HP, Turpeinen S, Niskanen EA, et al. Generation of lentivirus vectors using recombinant baculoviruses. Gene Ther 2008;15:1280-1286
31. Pluta K, Diehl W, Zhang XY, et al. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study. BMC Biotechnol 2007;7:41 (Pubitemid 47342599)
32. Moffat J, Grueneberg, Yang X, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content sreen. Cell 2006;124:1283-1298
33. Borawski J, Lindeman A, Buxton F, et al. Optimization procedure for small interfering RNA transfection in a 384-well format. J Biomol Screen 2007;12:546-559 (Pubitemid 46871827)
34. Borghouts C, Kunz C, Groner B. Peptide aptamer libraries. Comb Chem High Throughput Screen 2008;11:135-145 (Pubitemid 351347218)
35. de CB, Mikaelian I, Mathieu AL, et al. An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity. Mol Cell Proteomics 2007;6:451-459 (Pubitemid 46554540)
36. Bailey SN, Ali SM, Carpenter AE, et al. Microarrays of lentiviruses for gene function screens in immortalized and primary cells. Nat Methods 2006;3:117-122 (Pubitemid 43173310)
37. De La FR, Namkung W, Mills A, et al. Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel. Mol Pharmacol 2008;73:758-768
38. Tran J, Kung SK. Lentiviral vectors mediate stable and efficient gene delivery into primary murine natural killer cells. Mol Ther 2007;15:1331-1339 (Pubitemid 46965330)
39. Pan H, Mostoslavsky G, Eruslanov E, et al. Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages. J Immunol Methods 2008;329:31-44 (Pubitemid 350235459)
40. Kost TA, Condreay JP. Recombinant baculoviruses as expression vectors for insect and mammalian cells. Curr Opin Biotechnol 1999;10:428-33 41. Kost TA, Condreay JP. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol 2002;20:173-180 (Pubitemid 29457266)
41. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005;23:567-75 • Review on the development and use of baculoviral vectors for protein expression in insect cells and for gene delivery to mammalian cells.
42. Hu YC. Baculovirus vectors for gene therapy. Adv Virus Res 2006;68:287-320 (Pubitemid 44402214)
43. Hu YC. Baculoviral vectors for gene delivery: a review. Curr Gene Ther 2008;8:54-65 •• Excellent review on baculovirus-mediated gene delivery to mammalian cells. Highlights list of permissive cell types and describes recent developments and improvements to the system.
44. Lu L, Ho Y, Kwang J. Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochem Biophys Res Commun 2006;340:1178-1183 (Pubitemid 43083402)
45. Nicholson LJ, Philippe M, Paine AJ, et al. RNA interference mediated in human primary cells via recombinant baculoviral vectors. Mol Ther 2005;11:638-644 (Pubitemid 40353121)
46. Suzuki H, Kaneko H, Tamai N, et al. Suppression of HCV RNA replication by baculovirus-mediated shRNA expression. Nucleic Acids Symp Ser (Oxf) 2005;49:339-340
47. Kost TA, Condreay JP, Ames RS, et al. Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov Today 2007;12:396-403 (Pubitemid 46646990)
48. Condreay JP, Ames RS, Hassan NJ, et al. Baculoviruses and mammalian cell-based assays for drug screening. Adv Virus Res 2006;68:255-286 (Pubitemid 44402213)
49. Ames R, Fornwald J, Nuthulaganti P, et al. BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery. Receptors Channels 2004;10:99-107 (Pubitemid 39504306)
50. Ames RS, Kost TA, Condreay JP. BacMam technology and its application to drug discovery. Expert Opin Drug Discov 2007;2:1669-1681 (Pubitemid 350285353)
51. Boudjelal M, Mason SJ, Katso RM, et al. The application of BacMam technology in nuclear receptor drug discovery. Biotechnol Annu Rev 2005;11:101-125 (Pubitemid 41510275)
52. Ames R, Nuthulaganti P, Fornwald J, et al. Heterologous expression of G protein-coupled receptors in U-2 OS osteosarcoma cells. Receptors Channels 2004;10:117-124 (Pubitemid 39504308)
53. Medhurst AD, Atkins AR, Beresford IJ, et al. GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther 2007;321:1032-1045 (Pubitemid 46762709)
54. Behm DJ, Stankus G, Doe CP, et al. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems. Br J Pharmacol 2006;148:173-190 (Pubitemid 43873036)
55. Briscoe CP, Peat AJ, McKeown SC, et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol 2006;148:619-628 (Pubitemid 43993052)
56. Kenakin T, Jenkinson S, Watson C. Determining the potency and molecular mechanism of action of insurmountable antagonists. J Pharmacol Exp Ther 2006;319:710-723 (Pubitemid 44776375)
57. Watson C, Jenkinson S, Kazmierski W, et al. The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor. Mol Pharmacol 2005;67:1268-1282 (Pubitemid 40410427)
58. Jenkinson S, McCoy DC, Kerner SA, et al. Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology. J Biomol Screen 2003;8:463-470 (Pubitemid 40503601)
59. Magga J, Bart G, Oker-Blom C, et al. Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1. Biochem Pharmacol 2006;71:827-836 (Pubitemid 43208839)
60. Hoffman AF, Garippa RJ. A pharmaceutical company user's perspective on the potential of high content screening in drug discovery. Methods Mol Biol 2007;356:19-31
61. Pfohl JL, Worley JF III, Condreay JP, et al. Titration of KATP channel expression in mammalian cells utilizing recombinant baculovirus transduction. Receptors Channels 2002;8:99-111 (Pubitemid 34906178)
62. Gunthorpe MJ, Hannan SL, Smart D, et al. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that tnhibits the capsaicin-, acid-, and heat-mediated activation of the receptor. J Pharmacol Exp Ther 2007;321:1183-1192 (Pubitemid 46762715)
63. Fonfria E, Clay WC, Levy DS, et al. Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue. Br J Pharmacol 2008;153:544-556 (Pubitemid 351199022)
64. Clay WC, Condreay JP, Moore LB, et al. Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells. Assay Drug Dev Technol 2004;1:801-810
65. Katso RM, Parham JH, Caivano M, et al. Evaluation of cell-based assays for steroid nuclear receptors delivered by recombinant baculoviruses. J Biomol Screen 2005;10:715-724 (Pubitemid 41476806)
66. Hassan NJ, Pountney DJ, Ellis C, et al. BacMam recombinant baculovirus in transporter expression: a study of BCRP and OATP1B1. Protein Expr Purif 2006;47:591-598 (Pubitemid 43729033)
67. Wang DY, Lu Q, Walsh SL, et al. Development of a high-throughput cell-based assay for 11beta-hydroxysteroid dehydrogenase type 1 using BacMam technology. Mol Biotechnol 2008;39:127-134
68. Wang QZ, Lv YH, Diao Y, et al. The design of vectors for RNAi delivery system. Curr Pharm Des 2008;14:1327-1340 (Pubitemid 351997826)
69. Mizuguchi H, Kay MA, Hayakawa T. Approaches for generating recombinant adenovirus vectors. Adv Drug Deliv Rev 2001;52:165-176 (Pubitemid 33097543)
70. Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol 2007;36:184-204 (Pubitemid 350135911)
71. Schaffer DV, Koerber JT, Lim KI. Molecular engineering of viral gene delivery vehicles. Annu Rev Biomed Eng 2008;10:169-194
72. Geisse S. Insect cell cultivation and generation of recombinant baculovirus particles for recombinant protein production. In: Animal Cell Biotechnology: Methods and Protocols, 24th edition; Pörtner R (editor). 2007. p. 489-507
73. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463-8471 (Pubitemid 28471781)
74. Ma Q, Zhou L, Ma L, et al. Directional and direct cloning strategy for high-throughput generation of recombinant baculoviruses. BioTechniques 2006;41:453-458 (Pubitemid 46534884)
75. Sukman AJ, Kallarakal A, Fornwald J, et al. Generation of recombinant adenovirus vectors by a direct cloning approach. In: Gene cloning and expression technologies. Lu Q, Weiner MP, (editors), Eaton Publishing. 2002. p. 341-355
76. Kaba SA, Salcedo AM, Wafula PO, et al. Development of a chitinase and v-cathepsin negative bacmid for improved integrity of secreted recombinant proteins. J Virol Methods 2004;122:113-118 (Pubitemid 39370057)
77. Banaszynski LA, Chen LC, Maynard-Smith LA, et al. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 2006;126:995-1004 (Pubitemid 44310772)
78. Jarvis DL, Garcia A Jr. Long-term stability of baculoviruses stored under various conditions. BioTechniques 1994;16:508-513 (Pubitemid 2064266)
79. Tsai CT, Chan ZR, Lu JT, et al. Factors influencing the production and storage of baculovirus for gene delivery: An alternative perspective from the transducing titer assay. Enzyme Microbiol Technol 2007;40:1345-1351 (Pubitemid 46356548)
80. Braun A. Biosafety in handling gene transfer vectors. Curr Protoc Hum Genet 2006 ;Chapter 12: Unit.12.1 • Review on the biosafety issues related to the generation of viral vectors.
81. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 2000;7:20-23 (Pubitemid 30077144)
82. Kost TA, Condreay JP. Baculovirus vectors as gene transfer vectors for mammalian cells: biosafety considerations. Appl Biosafety 2002;7:167-9 •• Recommendations on the biosafety of BacMam vector generation and use.
83. Fontana L, Nuzzo M, Urbanelli L, et al. General strategy for broadening adenovirus tropism. J Virol 2003;77:11094-11104 (Pubitemid 37204299)
84. Chuang CK, Sung LY, Hwang SM, et al. Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering. 2007;14:1417-1424
85. Zeng J, Du J, Zhao Y, et al. Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 2007;25:1055-1061 (Pubitemid 46572604)
86. Ge J, Huang Y, Hu X, et al. A surface-modified baculovirus vector with improved gene delivery to B-lymphocytic cells. J Biotechnol 2007;129:367-372 (Pubitemid 46560169)
87. Organelle Lights™ reagents. 2007. Available from: http://www.invitrogen.com/content.cfm?pageid=11890 [Accessed 13 January 2009]
88. Available from: www.invitrogen.com
89. Hu YC, Tsai CT, Chang YJ, et al. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Prog 2003;19:373-379 (Pubitemid 36420985)
90. Condreay JP, Witherspoon SM, Clay WC, et al. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999;96:127-132 (Pubitemid 29036064)
91. Van DK, Hanahan D, Gluzman Y. Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA. J Virol 1984;50:606-614 (Pubitemid 14135793)
92. Abe T, Hemmi H, Miyamoto H, et al. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 2005;79:2847-2858 (Pubitemid 40270563)
93. Gronowski AM, Hilbert DM, Sheehan KC, et al. Baculovirus stimulates antiviral effects in mammalian cells. J Virol 1999;73:9944-9951
94. Grassi G, Kohn H, Dapas B, et al. Comparison between recombinant baculo- and adenoviral-vectors as transfer system in cardiovascular cells. Arch Virol 2006;151:255-271 (Pubitemid 43130586)
95. Clesham GJ, Adam PJ, Proudfoot D, et al. High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells. Gene Ther 1998;5:174-180 (Pubitemid 28077744)
96. Stilwell JL, Samulski RJ. Role of viral vectors and virion shells in cellular gene expression. Mol Ther 2004;9:337-346 (Pubitemid 38404522)
97. Andersson M, Warolen M, Nilsson J, et al. Baculovirus-mediated gene transfer and recombinant protein expression do not interfere with insulin dependent phosphorylation of PKB/Akt in human SHSY-5Y and C3A cells. BMC Cell Biol 2007;8:6 (Pubitemid 46379104)
98. Horrocks C, Halse R, Suzuki R, et al. Human cell systems for drug discovery. Curr Opin Drug Discov Devel 2003;6:570-575 (Pubitemid 36975359)
99. Hanson GT, Hanson BJ. Fluorescent probes for cellular assays. Comb Chem High Throughput Screen 2008;11:505-513
100. Premo Cameleon calcium sensor. 2008. Available from: http://www. invitrogen. com/site/us/en/home/Products-and-Services/Applications/Cell-and- Tissue-Analysis/Cellular-Imaging/Cell-Based-Reporter-Assays/Promo-Cameleon- Calcium-Sensor.html [Accessed 13 January 2009]
101. Jia Y, Gu XJ, Brinker A, et al. Measuring the tyrosine kinase activity: a review of biochemical and cellular assay technologies. Expert Opin Drug Discov 2008;3:959-978
102. TR-FRET assay development. 2008. Available from: http://www.invitrogen. com/site/us/en/home/Products-and-Services/Applications/Drug-Discovery/ Target-and-Lead-Identification-and-Validation/KinaseBiology/Kinase-Activity- Assays/LanthaScreen-TR-FRET-ToolBox/LanthaScreen-TR-FRET-Technology-Overview. html [Accessed 13 January 2009]
103. Douglas KL. Toward Development of Artificial Viruses for Gene Therapy: a comparative evaluation of viral and non-viral transfection. Biotechnol Prog 2008;24:871-883